IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 137 filers reported holding IRADIMED CORP in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $477,102 | +0.8% | 10,858 | +0.9% | 0.01% | +11.1% |
| Q1 2024 | $473,245 | -6.6% | 10,758 | +0.8% | 0.01% | -10.0% |
| Q4 2023 | $506,554 | +7.3% | 10,671 | +0.3% | 0.01% | 0.0% |
| Q3 2023 | $472,142 | -6.2% | 10,641 | +0.9% | 0.01% | 0.0% |
| Q2 2023 | $503,228 | +51.5% | 10,541 | +24.9% | 0.01% | +66.7% |
| Q1 2023 | $332,114 | +47.9% | 8,440 | +6.3% | 0.01% | +50.0% |
| Q4 2022 | $224,595 | -6.0% | 7,939 | +0.1% | 0.00% | -20.0% |
| Q3 2022 | $239,000 | -11.5% | 7,934 | +0.1% | 0.01% | 0.0% |
| Q2 2022 | $270,000 | -22.0% | 7,929 | +2.8% | 0.01% | 0.0% |
| Q1 2022 | $346,000 | +2.4% | 7,710 | +5.5% | 0.01% | +25.0% |
| Q4 2021 | $338,000 | -8.2% | 7,310 | -57.5% | 0.00% | 0.0% |
| Q3 2020 | $368,000 | – | 17,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 725,877 | $21,820,000 | 3.33% |
| Soleus Capital Management, L.P. | 684,690 | $20,582,000 | 2.80% |
| RK Capital | 351,841 | $10,576,000 | 2.71% |
| RESOURCE CONSULTING GROUP INC | 128,000 | $3,848,000 | 1.10% |
| Capital Impact Advisors, LLC | 20,370 | $575,000 | 0.57% |
| Ranger Investment Management | 195,935 | $5,890,000 | 0.46% |
| Hillsdale Investment Management Inc. | 121,300 | $3,646,000 | 0.33% |
| Bares Capital Management | 224,002 | $6,734,000 | 0.26% |
| CORNERCAP INVESTMENT COUNSEL INC | 30,808 | $926,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 76,206 | $2,291,000 | 0.13% |